Align Technology, Inc. (NASDAQ:ALGN) Shares Acquired by Huntington National Bank

Huntington National Bank increased its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 103.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 326 shares of the medical equipment provider’s stock after acquiring an additional 166 shares during the quarter. Huntington National Bank’s holdings in Align Technology were worth $68,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Picton Mahoney Asset Management raised its position in shares of Align Technology by 69.9% during the 4th quarter. Picton Mahoney Asset Management now owns 141 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 58 shares during the period. Neo Ivy Capital Management acquired a new stake in Align Technology in the third quarter worth $32,000. Private Trust Co. NA increased its position in Align Technology by 113.4% in the fourth quarter. Private Trust Co. NA now owns 175 shares of the medical equipment provider’s stock worth $36,000 after buying an additional 93 shares during the period. Versant Capital Management Inc boosted its holdings in shares of Align Technology by 212.2% during the fourth quarter. Versant Capital Management Inc now owns 231 shares of the medical equipment provider’s stock valued at $48,000 after acquiring an additional 157 shares during the period. Finally, Newbridge Financial Services Group Inc. bought a new position in shares of Align Technology during the fourth quarter worth about $52,000. Institutional investors own 88.43% of the company’s stock.

Align Technology Stock Down 0.5 %

Shares of Align Technology stock opened at $153.51 on Monday. Align Technology, Inc. has a 12 month low of $138.00 and a 12 month high of $331.64. The stock has a market cap of $11.24 billion, a PE ratio of 27.36, a price-to-earnings-growth ratio of 2.24 and a beta of 1.73. The business has a fifty day simple moving average of $186.45 and a 200-day simple moving average of $211.38.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.43 by ($0.47). Align Technology had a return on equity of 13.84% and a net margin of 10.54%. Analysts expect that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently weighed in on ALGN. Leerink Partnrs raised shares of Align Technology from a “hold” rating to a “strong-buy” rating in a report on Monday, January 6th. Leerink Partners upgraded shares of Align Technology from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $235.00 to $280.00 in a research note on Monday, January 6th. Bank of America increased their price target on Align Technology from $200.00 to $206.00 and gave the company an “underperform” rating in a research note on Friday, December 13th. Mizuho lowered their target price on Align Technology from $295.00 to $250.00 and set an “outperform” rating on the stock in a report on Tuesday, March 25th. Finally, Jefferies Financial Group cut their price target on shares of Align Technology from $285.00 to $260.00 and set a “buy” rating for the company in a report on Thursday, January 23rd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $262.64.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.